Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations (2019 - 2020)

Cumberland Pharmaceuticals' Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 1247011.0 for Q1 2020.

  • For Q1 2020, Liabilities from Discontinued Operations changed N/A year-over-year to 1247011.0; the TTM value through Mar 2020 reached 1247011.0, changed N/A, while the annual FY2019 figure was 2151357.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q1 2020 was 1247011.0 at Cumberland Pharmaceuticals, down from 2151357.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 2151357.0 in Q4 2019 and bottomed at 1247011.0 in Q1 2020.